Compare MCK & RCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCK | RCL |
|---|---|---|
| Founded | 1833 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.5B | 81.6B |
| IPO Year | 1995 | 1997 |
| Metric | MCK | RCL |
|---|---|---|
| Price | $889.12 | $264.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 18 |
| Target Price | ★ $952.92 | $353.44 |
| AVG Volume (30 Days) | 784.2K | ★ 1.5M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | 0.40% | ★ 2.36% |
| EPS Growth | ★ 49.22 | 42.69 |
| EPS | 5.15 | ★ 7.68 |
| Revenue | ★ $112,084,000,000.00 | $8,777,845,000.00 |
| Revenue This Year | $14.94 | $10.97 |
| Revenue Next Year | $8.21 | $7.36 |
| P/E Ratio | $176.31 | ★ $34.64 |
| Revenue Growth | ★ 3.11 | N/A |
| 52 Week Low | $687.68 | $232.10 |
| 52 Week High | $999.00 | $356.39 |
| Indicator | MCK | RCL |
|---|---|---|
| Relative Strength Index (RSI) | 54.89 | 27.81 |
| Support Level | $800.61 | $263.67 |
| Resistance Level | $900.58 | $295.69 |
| Average True Range (ATR) | 20.52 | 7.13 |
| MACD | 0.71 | -2.84 |
| Stochastic Oscillator | 63.51 | 11.40 |
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Royal Caribbean is the world's second-largest cruise company by revenues, operating 71 ships across five global and partner brands in the cruise vacation industry. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises. The selection of brands in the portfolio allows Royal to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in 2021, plans to launch its new Celebrity River Cruise brand in 2027, and is set to operate eight private destination locations by 2028.